Skip to content

Robert Tennant

Chief Executive Officer at Iyuda Therapeutics.

Earliest Form D on file: Apr 2026

Filed Apr 6, 2026

Iyuda Therapeutics

Off-the-shelf donor cell therapy for cancer

Biotech, Owings Mills MD

Signed as Chief Executive Officer

$600K

sold of $600K offered

Form D

Network

At Iyuda Therapeutics

1 person